S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q3 2021

Avoro Capital Advisors

Periodo: Q3 2021 Β· Depositato: 2021-11-15
Vedi su SEC EDGAR β†—
AUM
$6.37B
Valore totale del portafoglio
Posizioni
47
Titoli dichiarati
Prima Posizione
HZNP
15.5% $985.9M
Var. Trimestrali
+6 / -7
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-11-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
HZNPHORIZON THERAPEUTICS PLC$985.9M15.49%β€”β€”
15.5%
MRTXMIRATI THERAPEUTICS INC$884.5M13.89%β€”β€”
13.9%
XLRNACCELERON PHARMA INC$688.4M10.81%β€”β€”
10.8%
UTHRUNITED THERAPEUTICS CORP$553.7M8.70%$184.58$555.91+201.2%
8.7%
ASNDASCENDIS PHARMA$315.6M4.96%$159.39$274.50+72.2%
5.0%
ARGXARGENX SE$285.8M4.49%$302.00$939.68+211.2%
4.5%
SRPTSAREPTA THERAPEUTICS INC$231.2M3.63%$92.48$19.28-79.2%
3.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$209.6M3.29%$24.66$4.31-82.5%
3.3%
ARNAARENA PHARMACEUTICALS INC$204.0M3.20%β€”β€”
3.2%
FOLDAMICUS THERAPEUTICS INC$168.8M2.65%β€”β€”
2.6%
APLSAPELLIS PHARMACEUTICALS INC$164.8M2.59%$32.96β€”
2.6%
ALNYALNYLAM PHARMACEUTICALS INC$160.5M2.52%$188.81$312.78+65.7%
2.5%
BMRNBIOMARIN PHARMACEUTICAL INC$144.9M2.28%$77.29$58.99-23.7%
2.3%
VRTXVERTEX PHARMACEUTICALS INC$120.4M1.89%$181.39$528.04+191.1%
1.9%
ISEEIVERIC BIO INC$115.3M1.81%β€”β€”
1.8%
MDGLMADRIGAL PHARMACEUTICALS INC$113.7M1.79%$79.79$528.10+561.9%
1.8%
TRILLIUM THERAPEUTICS INC$100.1M1.57%β€”β€”
1.6%
PMVPPMV PHARMACEUTICALS INC$87.2M1.37%$29.80$1.22-95.9%
1.4%
KURAKURA ONCOLOGY INC$74.9M1.18%$18.73$11.10-40.7%
1.2%
MRSNMERSANA THERAPEUTICS INC$64.1M1.01%β€”β€”
1.0%
GLUEMONTE ROSA THERAPEUTICS INC$61.0M0.96%$22.28$24.21+8.7%
1.0%
XENEXENON PHARMACEUTICALS INC$55.8M0.88%$15.28$60.96+298.9%
0.9%
WHWKAADI BIOSCIENCES INC$53.7M0.84%$29.37$4.19-85.7%
0.8%
MNKDMANNKIND CORP$38.3M0.60%$4.35$4.52+3.9%
0.6%
CBAYCYMABAY THERAPEUTICS INC$37.6M0.59%β€”β€”
0.6%
MRNSMARINUS PHARMACEUTICALS INC$36.8M0.58%β€”β€”
0.6%
ACADACADIA PHARMACEUTICALS INC$36.5M0.57%$16.61$25.97+56.4%
0.6%
DCPHDECIPHERA PHARMACEUTICALS INC$36.3M0.57%β€”β€”
0.6%
AMRNXXXXAMARIN CORP PLC$30.6M0.48%β€”β€”
0.5%
PRAXPRAXIS PRECISION MEDICINES INC$29.6M0.46%$277.35$318.52+14.8%
0.5%

AttivitΓ  Trimestre su Trimestre

Q3 2021 vs. Q2 2021

Nuove Posizioni (6)

TickerEmittenteNozionaleDal Deposito
WHWKAADI BIOSCIENCES INC$53.7M-85.7%
KYMRKYMERA THERAPEUTICS INC$26.8M
DICEDICE THERAPEUTICS INC$26.2M
BIIBBIOGEN INC$23.8M
NUVLNUVALENT INC$22.3M
TNGXTANGO THERAPEUTICS INC$20.0M

Posizioni Chiuse (7)

TickerEmittenteNozionale
CNSTCONSTELLATION PHARMACEUTICALS INC$108.5M
RLMDRELMADA THERAPEUTICS INC$29.9M
OLMAOLEMA PHARMACEUTICALS INC$24.5M
CNTACENTESSA PHARMACEUTICALS PLC$11.1M
BCTGBCTG ACQUISITION CORP$9.1M
ADAPYADAPTIMMUNE THERAPEUTICS PLC$8.6M
ARPOAERPIO PHARMACEUTICALS INC$7.6M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
APLSCALLAPELLIS PHARMACEUTICALS INC$161.4M+1983.3%
APLSCALLAPELLIS PHARMACEUTICALS INC$-2.1M+531.2%
ALNYALNYLAM PHARMACEUTICALS INC$159.1M+466.7%+65.7%
APLSCALLAPELLIS PHARMACEUTICALS INC$101.3M+397.4%
RNAMAVIDITY BIOSCIENCES INC$14.9M+111.0%
PMVPPMV PHARMACEUTICALS INC$24.8M+60.3%-95.9%
APLSCALLAPELLIS PHARMACEUTICALS INC$-62.3M+50.7%
FOLDAMICUS THERAPEUTICS INC$48.8M+42.0%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
IOVACALLIOVANCE BIOTHERAPEUTICS INC$-235.2M-92.9%-82.5%
SRPTCALLSAREPTA THERAPEUTICS INC$-184.4M-91.7%-79.2%
XLRNCALLACCELERON PHARMA INC$-376.4M-84.1%
SNDXSYNDAX PHARMACEUTICALS INC$-22.0M-48.5%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$-7.1M-47.9%
MRUSMERUS N V$-4.0M-31.8%
ARNAARENA PHARMACEUTICALS INC$-74.0M-16.0%
VRTXVERTEX PHARMACEUTICALS INC$-38.8M-15.9%+191.1%
← Torna agli Hedge Fund